Abstract Body

HIV is associated with accelerated lung aging and Chronic Obstructive Pulmonary Disease(COPD). There remain gaps in our understanding of features unique to HIV-associated COPD and the HIV lung aging phenotype. The development of parametric response mapping(PRM) CT analysis, with joint analysis of inspiratory and expiratory CTs, allows for detection and quantification of small airways dysfunction that is associated with lung aging and was previously undetectable by conventional CT. Small airways dysfunction, is tied to greater respiratory morbidity, independent of lung function(FEV1). We aimed to leverage PRM to phenotype HIV-associated COPD and describe the burden of small airways dysfunction.

We utilized data from the Study of HIV in the Etiology of Lung Disease(SHIELD) COPD sub-study, which phenotypes COPD among PLWH and HIV-uninfected individuals with matched risk factors. Participants completed lung function and Chest CT evaluation. COPD was confirmed by post-bronchodilator spirometry. PRM was applied to CT images to quantify percentages of small airways disease(PRM[sup]fSAD[/sup]) and emphysema(PRMemph). To describe small airways dysfunction in HIV-COPD, quantile regression models were generated, given highly skewed outcomes, with adjustment for relevant confounders, including demographics, FEV1, pack-years, and injection drug use.

We studied 353 participants; 240 PLWH(68%) and 137 with COPD(39%). Among those with COPD, the majority had mild-moderate airflow obstruction(median FEV1% predicted 72[60-85]) and minimal emphysema(0.52%[0.12-2.03]). For those without COPD, there was no difference in PRMfSAD by HIV. After adjusting for cofounders, including FEV1, greater PRMfSAD was observed in HIV+ COPD (median estimate 14.3%; 95%CI 11.2-17.4) than in HIV-uninfected participants with COPD(10.4%; 95%CI 7.38-13.5)(p=0.031). The highest PRMfSAD was observed in those with CD4+ counts<350(17.3%; 95%CI 13.0-21.6)(Figure). In adjusted models, aside from HIV, age was the only factor associated with PRMfSAD. There was higher PRMemph in HIV+ COPD as well (p=0.046), though emphysema was minimal in the cohort.

HIV+ COPD is characterized by an increased burden of small airways dysfunction, even in a cohort with higher lung function. Our study suggests that PRM adds value in describing early lung aging in HIV. Longitudinal studies are now warranted to describe the long term impact, and drivers of, small airways dysfunction in HIV.